头孢他啶在老年志愿者中的药代动力学。
Pharmacokinetics of ceftazidime in elderly volunteers.
作者信息
LeBel M, Barbeau G, Vallee F, Bergeron M G
出版信息
Antimicrob Agents Chemother. 1985 Nov;28(5):713-5. doi: 10.1128/AAC.28.5.713.
Abstract
The pharmacokinetics of ceftazidime after a 1-g bolus dose were studied in six elderly volunteers and 12 young subjects. Serum and urine samples were collected in serial order for 24 h and assayed by high-pressure liquid chromatography. The ceftazidime renal clearance was reduced in elderly subjects, a symptom related to normal aging of the kidneys. The decrease in volume of distribution in the elderly group may be explained by a reduction in total body water and an increase in fat tissue. Dosage adjustment is probably not necessary for otherwise healthy elderly patients requiring ceftazidime.
摘要
对6名老年志愿者和12名年轻受试者静脉注射1克头孢他啶后的药代动力学进行了研究。按顺序连续24小时采集血清和尿液样本，并用高压液相色谱法进行分析。老年受试者的头孢他啶肾清除率降低，这是与肾脏正常老化相关的症状。老年组分布容积的减少可能是由于总体液减少和脂肪组织增加所致。对于其他方面健康但需要使用头孢他啶的老年患者，可能无需调整剂量。
相似文献
1
Pharmacokinetics of ceftazidime in elderly volunteers.头孢他啶在老年志愿者中的药代动力学。
Antimicrob Agents Chemother. 1985 Nov;28(5):713-5. doi: 10.1128/AAC.28.5.713.
2
Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis.
Chemotherapy. 1985;31(6):410-6. doi: 10.1159/000238368.
3
Single- and multiple-dose pharmacokinetics of ceftazidime in infected patients with varying degrees of renal function.
J Clin Pharmacol. 1989 Apr;29(4):331-7. doi: 10.1002/j.1552-4604.1989.tb03337.x.
4
Pharmacokinetics and dose proportionality of cefmetazole in healthy young and elderly volunteers.头孢美唑在健康青年和老年志愿者体内的药代动力学及剂量比例关系
Antimicrob Agents Chemother. 1990 Oct;34(10):1944-8. doi: 10.1128/AAC.34.10.1944.
5
Pharmacokinetics of ceftazidime in elderly patients and young volunteers.头孢他啶在老年患者和年轻志愿者中的药代动力学。
Scand J Infect Dis. 1984;16(3):325-6. doi: 10.3109/00365548409070410.
6
Effects of age and gender on pharmacokinetics of cefepime.年龄和性别对头孢吡肟药代动力学的影响。
Antimicrob Agents Chemother. 1992 Jun;36(6):1181-5. doi: 10.1128/AAC.36.6.1181.
7
Pharmacokinetics of ceftazidime in patients with renal insufficiency.头孢他啶在肾功能不全患者中的药代动力学。
Antimicrob Agents Chemother. 1984 Feb;25(2):201-4. doi: 10.1128/AAC.25.2.201.
8
The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy.头孢他啶在肾功能受损且同时接受速尿治疗患者中的药代动力学。
Eur J Clin Pharmacol. 1988;35(3):273-9. doi: 10.1007/BF00558265.
9
Pharmacokinetics and tissue concentrations of ceftazidime in burn patients.头孢他啶在烧伤患者中的药代动力学及组织浓度
Eur J Clin Pharmacol. 1988;35(5):543-9. doi: 10.1007/BF00558251.
10
The pharmacokinetics and safety of ceftazidime in the neonate.头孢他啶在新生儿中的药代动力学及安全性
J Antimicrob Chemother. 1985 Jan;15(1):97-103. doi: 10.1093/jac/15.1.97.
引用本文的文献
1
Application of Physiologically Based Pharmacokinetic Model to Delineate the Impact of Aging and Renal Impairment on Ceftazidime Clearance.基于生理的药代动力学模型在描述衰老和肾功能损害对头孢他啶清除率影响中的应用。
Antibiotics (Basel). 2024 Sep 9;13(9):862. doi: 10.3390/antibiotics13090862.
2
Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病急性加重患者中头孢他啶和亚胺培南的群体药代动力学及剂量优化
Pharmaceutics. 2021 Mar 27;13(4):456. doi: 10.3390/pharmaceutics13040456.
3
Correlation of the pharmacokinetic parameters of amikacin and ceftazidime.阿米卡星与头孢他啶药代动力学参数的相关性
Clin Pharmacokinet. 2007;46(10):859-66. doi: 10.2165/00003088-200746100-00004.
4
Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections.头孢他啶持续输注与间歇给药用于疑似革兰阴性菌感染的重症患者的比较。
Antimicrob Agents Chemother. 1996 Mar;40(3):691-5. doi: 10.1128/AAC.40.3.691.
5
Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.SCE - 2787与头孢他啶的比较药代动力学及血清杀菌活性
Antimicrob Agents Chemother. 1993 Sep;37(9):1835-41. doi: 10.1128/AAC.37.9.1835.
6
Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.头孢他啶。其抗菌活性、药代动力学特性及治疗效果的最新进展。
Drugs. 1995 Apr;49(4):577-617. doi: 10.2165/00003495-199549040-00008.
7
Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model.在体外感染模型中，头孢吡肟、头孢他啶、头孢噻肟和头孢曲松对金黄色葡萄球菌以及产β-内酰胺酶的产气肠杆菌和肺炎克雷伯菌的杀菌活性。
Antimicrob Agents Chemother. 1995 Aug;39(8):1764-71. doi: 10.1128/AAC.39.8.1764.
8
Pharmacokinetics of cefoperazone in ambulatory elderly volunteers compared with young adults.头孢哌酮在老年门诊志愿者与年轻成年人中的药代动力学比较。
Antimicrob Agents Chemother. 1987 Jun;31(6):925-9. doi: 10.1128/AAC.31.6.925.
9
Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill males.头孢他啶在年轻、健康及老年急性病男性中的比较药代动力学。
Eur J Clin Pharmacol. 1988;34(2):179-86. doi: 10.1007/BF00614556.
10
Influence of age on the pharmacokinetics of ceftazidime in acutely ill, adult patients.
Eur J Clin Pharmacol. 1988;34(2):173-8. doi: 10.1007/BF00614555.
本文引用的文献
1
Biological determinants of altered pharmacokinetics in the elderly.老年人药代动力学改变的生物学决定因素。
Gerontology. 1982;28 Suppl 1:8-17. doi: 10.1159/000212568.
2
[Calculation of initial values of pharmacokinetic using a programmable calculator].
Therapie. 1983 Jan-Feb;38(1):21-6.
3
Pharmacokinetics of ceftazidime in elderly patients and young volunteers.头孢他啶在老年患者和年轻志愿者中的药代动力学。
Scand J Infect Dis. 1984;16(3):325-6. doi: 10.3109/00365548409070410.
4
Ceftazidime: pharmacokinetics in young volunteers versus elderly patients and therapeutic efficacy with complicated urinary tract infections.头孢他啶：年轻志愿者与老年患者的药代动力学及复杂尿路感染的治疗效果
J Antimicrob Chemother. 1983 Jul;12 Suppl A:41-5. doi: 10.1093/jac/12.suppl_a.41.
5
Statistical estimations in pharmacokinetics.药物动力学中的统计学估计
J Pharmacokinet Biopharm. 1974 Apr;2(2):123-48. doi: 10.1007/BF01061504.
6
Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢他啶。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1985 Feb;29(2):105-61. doi: 10.2165/00003495-198529020-00002.
7
Prediction of creatinine clearance from serum creatinine.根据血清肌酐预测肌酐清除率。
Nephron. 1976;16(1):31-41. doi: 10.1159/000180580.
8
Nonlinear least-squares regression programs for microcomputers.适用于微型计算机的非线性最小二乘回归程序。
J Pharmacokinet Biopharm. 1979 Oct;7(5):537-41. doi: 10.1007/BF01062394.
Zotero 插件